NCT07322263
- Conditions
- BCG-Refractory Bladder Cancer, BCG-Unresponsive Bladder Cancer, Bladder Cancer, +25 more
- Locations
-
- University of Iowa Iowa City, Iowa, United States
Clinical trial condition
Carcinoma in Situ (CIS)
Explore clinical trials studying Carcinoma in Situ (CIS). Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study